natgillin/translations-raw huggingface dataset:
Similarly a larger effect was observed in Parkinson’s disease patients with visual hallucinations (see section 5.1).
Opazili so ga tudi pri tistih bolnikih s Parkinsonovo boleznijo, ki so imeli vidne halucinacije (glejte poglavje 5.1).
Similarly a larger effect was observed in Parkinson’s disease patients with visual hallucinations (see section 5.1).
Podobno so večji učinek opazili pri bolnikih s Parkinsonovo boleznijo z vidnimi halucinacijami (glejte poglavje 5.1).
Similarly a larger effect was observed in Parkinson’s disease patients with visual hallucinations (see section 5.1).
Prav tako so boljši učinek opazili pri tistih bolnikih s Parkinsonovo boleznijo, ki so imeli vidne halucinacije (glejte poglavje 5.1).
Similarly a larger effect was observed in Parkison’s disease patients with visual hallucinations (see section 5.1).
Podobno so večji učinek opazili pri bolnikih s Parkinsonovo boleznijo z vidnimi halucinacijami (glejte poglavje 5.1).
Similarly administration of fosamprenavir with ritonavir may modify the pharmacokinetics of other active substances that share this metabolic pathway.
Podobno lahko tudi dajanje fosamprenavirja v kombinaciji z ritonavirjem spremeni farmakokinetične lastnosti drugih zdravilnih učinkovin, ki si delijo to presnovno pot.
Similarly from the VAERS, in 113 reports of pregnant women who had received MedImmune’s (H1N1) 2009 Monovalent Vaccine Live, Intranasal, no unusual patterns of pregnancy complications or foetal outcomes were observed.
Prav tako na podlagi VAERS niso ugotovili neobičajnih vzorcev zapletov med nosečnostjo ali izidov pri plodu v 113 poročilih o nosečnicah, ki so prejele MedImmune-ovo (H1N1) 2009 monovalentno živo cepivo intranazalno.
Similarly the risk/benefit of continued Rapamune therapy should be re-evaluated in patients with severe refractory hyperlipidaemia.
Podobno je treba pri bolnikih s hudo trdovratno hiperlipidemijo pretehtati korist in tveganje nadaljnje terapije z zdravilom Rapamune.
Similarly to adults, the recommended dose in children and adolescents aged 1 – 18 years is 5,000 U per m² BSA given every third day.
Podobno kot pri odraslih je priporočeni odmerek pri otrocih in mladostnikih, starih 1-18 let, 5.000 E na m² telesne površine, ki se daje vsak tretji dan.
Similarly, a good to moderate European League Against Rheumatism (EULAR) response was achieved by significantly more MabThera treated patients treated with MabThera and methotrexate compared to patients treated with methotrexate alone (Table 10).
Podobno je v vseh študijah dober do zmeren odziv po klasifikaciji Evropske lige za boj proti revmatizmu (EULAR, European League Against Rheumatism) doseglo pomembno več bolnikov, ki so se zdravili z zdravilom MabThera in metotreksatom, kakor bolnikov, ki so se zdravili samo z metotreksatom (preglednica 10).
Similarly, a greater proportion of patients achieved at least the MCID for Incruse at Week 24 (44%) compared with placebo (34%) in the 24-week study.
Podobno je v 24-tedenskih študiji po 24 tednih vsaj minimalno klinično pomembno razliko s 55 mikrogrami zdravila Incruse dosegel večji delež bolnikov (44 %) kot s placebom (34 %).
Similarly, a greater proportion of patients achieved 1 unit TDI focal score for Incruse (53%) compared with placebo (41%) at Week 24 in the 24-week study.
Podobno je v 24-tedenskih študiji po 24 tednih dosegel  1 enoto fokalnega seštevka TDI večji delež bolnikov z zdravilom Incruse (53 %) kot s placebom (41 %).
Similarly, a yellow fever vaccine was given concomitantly with Dukoral, and there was no interaction observed with the immune response to the yellow fever vaccine.
V podobni raziskavi so sočasno dajali cepivo proti rumeni mrzlici in Dukoral ter niso opazili interakcij pri imunskem odzivu na cepivo proti rumeni mrzlici.
Similarly, as deferiprone is metabolised in the liver, caution must be exercised in patients with hepatic dysfunction.
Deferipron se presnavlja tudi v jetrih, zato je potrebna večja pazljivost pri bolnikih z disfunkcijo jeter.
Similarly, darunavir use in OBT in darunavir-naïve patients was counted as one active drug in OBT.
Podobno je bila pri bolnikih, ki še niso prejemali darunavirja, uporaba darunavirja v okviru OBT upoštevana kot uporaba enega aktivnega zdravila.
Similarly, feeding a high protein/low carbohydrate diet may alter insulin requirements (e.g. decrease of insulin dose).
Podobno lahko hrana, bogata z beljakovinami in revna z ogljikovimi hidrati, spremeni potrebo po insulinu (npr. zmanjšanje odmerka insulina).
Similarly, feeding a high protein/low carbohydrate diet may alter insulin requirements (e.g. decrease of insulin dose).
Podobno lahko hrana, bogata z beljakovinami in z malo ogljikovimi hidrati, spremeni potrebo po insulinu (npr. zmanjšanje odmerka insulina).
Similarly, greater proportions of children treated with the abacavir containing combinations had HIV-1 RNA 50 copies/ml at 48 weeks (53%, 42% and 28% respectively, p=0.07).
Podobno je imel večji delež otrok zdravljenih s kombinacijami z abakavirjem < 50 kopij/ml HIV-1 RNA v 48. tednu (53 %, 42 % in 28 %, p = 0,07).
Similarly, if ZACTRAN comes into direct contact with skin the affected area should be washed immediately with clean water.
Če pride do stika zdravila s kožo, takoj umijte izpostavljene dele s čisto vodo.
Similarly, in a 26-week clinical trial, patients with type 2 diabetes and moderate renal impairment (CrCL 30-59 mL/min) had 26% lower liraglutide exposure when compared with a separate trial including patients with type 2 diabetes with normal renal function or mild renal impairment.
Podobno so v 26-tedenskem kliničnem preskušanju pri bolnikih s sladkorno boleznijo tipa 2 in zmerno okvaro ledvic (očistek kreatinina 30-59 ml/min) ugotovili 26 % manjšo izpostavljenost liraglutidu kot v ločenem preskušanju, ki je zajelo bolnike s sladkorno boleznijo tipa 2 z normalnim delovanjem ledvic ali blago okvaro ledvic.
Similarly, in a 26­week clinical trial, patients with type 2 diabetes and moderate renal impairment (CrCL 30­59 ml/min, see section 5.1) had 26% lower liraglutide exposure when compared with a separate trial including patients with type 2 diabetes with normal renal function or mild renal impairment.
Podobno so v 26-tedenskem kliničnem preskušanju pri bolnikih s sladkorno boleznijo tipa 2 in zmerno okvaro ledvic (očistek kreatinina 30-59 ml/min, glejte poglavje 5.1) ugotovili 26 % manjšo izpostavljenost liraglutidu kot v ločenem preskušanju, ki je zajelo bolnike s sladkorno boleznijo tipa 2 z normalnim delovanjem ledvic ali blago okvaro ledvic.
Similarly, in all studies a good to moderate European League Against Rheumatism (EULAR) response was achieved by significantly more MabThera treated patients treated with MabThera and methotrexate compared to patients treated with methotrexate alone (Table 10).
Podobno je v vseh študijah dober do zmeren odziv po klasifikaciji Evropske lige za boj proti revmatizmu (EULAR, European League Against Rheumatism) doseglo pomembno več bolnikov, ki so se zdravili z zdravilom MabThera in metotreksatom, kakor bolnikov, ki so se zdravili samo z metotreksatom (preglednica 10).
Similarly, in an ICGG Gaucher Registry analysis of bone mineral density using dual-energy X-ray absorptiometry (DXA) in 342 patients, after 8 years of treatment normal bone mineral density was achieved with a Cerezyme dose of 60 U/kg body weight once every 2 weeks, but not with lower doses of 15 and 30 U/kg body weight once every 2 weeks (Wenstrup et al, 2007).
Podobno je analiza Gaucherjevega registra ICGG za mineralno gostoto kosti, z uporabo dvo- energetske rentgenske absorpciometrije (dual-energy X-ray absorptiometry, DXA) pri 342 bolnikih, pokazala, da je bila po 8-ih letih zdravljenja dosežena normalna mineralna gostota kosti z odmerkom zdravila Cerezyme v višini 60 enot/kg telesne mase enkrat na vsaka 2 tedna, vendar pa ne pri nižjih odmerkih v višini 15 in 30 enot/kg telesne mase na vsaka 2 tedna (Wenstrup et al, 2007).
Similarly, in another study in 355 patients, those treated with Cyramza plus best supportive care lived significantly longer than patients treated with placebo plus best supportive care (an average of 5.2 months versus
Podobno so v drugi študiji s 355 bolniki tisti, ki so jih zdravili z zdravilom Cyramza v kombinaciji z najboljšo podporno nego, živeli bistveno dlje kot bolniki, ki so jih zdravili s placebom v kombinaciji z najboljšo podporno nego (v povprečju 5,2 meseca v primerjavi s 3,8 meseca).
Similarly, in cultures of human Burkitt’s B-lymphoma cells, the production of immunoglobulin M protein in response to IL-6 was dose-dependently inhibited by siltuximab.
Prav tako je siltuksimab v odvisnosti od odmerka zaviral z IL-6 stimulirano nastajanje proteina imunoglobulina M v kulturah celic B človeškega Burkittovega limfoma.
Similarly, in the prophylaxis studies, the mean steady-state posaconazole average concentration (Cav) was comparable among ten adolescents (13-17 years of age) to Cav achieved in adults (≥ 18 years of age).
profilaktične uporabe zdravila srednja vrednost povprečne koncentracije posakonazola v stanju dinamičnega ravnovesja (Cav) pri desetih mladostnikih (starih od 13 do 17 let) podobna vrednosti Cav, doseženi pri odraslih (starih ≥ 18 let).
Similarly, in the RUTH study, raloxifene did not affect the incidence of myocardial infarction, hospitalized acute coronary syndrome, stroke or overall mortality, including overall cardiovascular mortality, compared to placebo (for the increase in risk of fatal stroke see section 4.4).
Podobno v študiji RUTH raloksifen v primerjavi s placebom ni vplival na incidenco miokardnega infarkta, hospitalizacije akutnega koronarnega sindroma, možganske kapi ali celokupno smrtnost, vključno s celokupno kardiovaskularno smrtnostjo (za povečanje tveganja smrtne kapi glejte poglavje 4.4).
Similarly, in UA/NSTEMI patients with life threatening conditions that require urgent revascularisation, the use of fondaparinux prior to and during PCI is not recommended.
Tudi pri ogroženih bolnikih z UA/NSTEMI, ki zahtevata urgentno
Similarly, no plasma clearance differences were observed between black and Caucasian patients undergoing orthopaedic surgery.
Podobno niso opazili razlik v plazemskem očistku med temnopoltimi in belopoltimi bolniki po ortopedskih operacijah.
Similarly, patients with atrial fibrillation are at high risk of clots forming in the heart, which can reach the brain where they can cause a stroke.
Podobno obstaja pri bolnikih z atrijsko fibrilacijo veliko tveganje za nastajanje strdkov v srcu, ki lahko dosežejo možgane in povzročijo kap.
Similarly, recent treatment with hepatotoxic or haematotoxic medicinal products (e.g. methotrexate) may result in increased side effects; therefore, the initiation of leflunomide treatment has to carefully be considered regarding these benefit/risk aspects and closer monitoring is recommended in the init ial phase after switching.
Podobno lahko nedavno zdravljenje s hepatotoksičnimi ali hematotoksičnimi zdravili (npr. z metotreksatom) zveča tveganje za pojav neželenih učinkov; zato je treba uvedbo zdravljenja z leflunomidom skrbno pretehtati upoštevaje koristi in tveganja; v začetnem obdobju po zamenjavi je priporočljivo natančnejše nadziranje.
Similarly, studies in animals have shown excretion of cobicistat/metabolites in milk.
Študije na živalih so tudi pokazale, da se kobicistat/presnovki izločajo v mleko.
Similarly, the exposure to metabolite, AZ5104 decreased by 82% for the AUC and 78% for Cmax.
Podobno se je zmanjšala izpostavljenost presnovku AZ5104 (AUC za 82 % in Cmax za 78 %).
Similarly, the geometric mean AUC (CV%) values at Cycle 6 were higher among the subcutaneous group than the intravenous group; 4088 µgday/mL (34.2) versus 3630 µgday/mL (32.8) respectively) with a resulting adjusted geometric mean ratio [90% CI] of 1.10 [0.98-1.24].
Podobno so bile geometrične sredine AUC (KV %) v 6. ciklu višje pri skupini, ki je zdravilo prejemala podkožno, kot pri skupini, ki ga je prejemala intravensko; geometrična sredina AUC (KV %) je bila s podkožno obliko 4088 µgdan/ml (34,2) in z intravensko obliko 3630 µgdan/ml (32,8); prilagojeno razmerje geometričnih sredin [90-% IZ] je bilo 1,10 [0,98–1,24].
Similarly, there was no clinically significant pharmacokinetic interaction of Trazec with other oral antidiabetic agents such as metformin or glibenclamide.
Prav tako ni bilo klinično pomembnih farmakokinetičnih interakcij Trazeca z drugimi peroralnimi antidiabetiki, na primer z metforminom ali glibenklamidom.
Similarly, there was no detectable effect of age in a population pharmacokinetic analysis of Abilify Maintena in schizophrenia patients.
Tudi v populacijski farmakokinetični analizi zdravila Abilify Maintena pri shizofrenih bolnikih niso našli opaznega vpliva starosti.
Similarly, volumetric trabecular BMD at the total hip increased by 4.7.
Podobno se je volumetrični trabekularni BMD celotnega kolka povečal za 4,7%.
Similarly, when Perjeta was administered in combination with TCH (docetaxel, carboplatin and trastuzumab) for 6 cycles, the most common ADRs (≥50%) were diarrhoea and alopecia.
Ko so zdravilo Perjeta dajali v kombinaciji s shemo TCH (docetaksel, karboplatin in trastuzumab) v 6 ciklih, sta bila podobno najpogostejšna neželena učinka (≥ 50 %) diareja in alopecija.
Simoctocog alfa (human coagulation factor VIII (rDNA)) is a purified protein that has 1440 amino acids.
Simoktokog alfa (humani koagulacijski faktor VIII (rDNK)) je očiščena beljakoviina s 1440 aminokislinami.
Simoctocog alfa is made by a method known as ‘recombinant DNA technology’: it is made by cells into which a gene (part of the DNA) has been introduced that make them able to produce it.
Simoktokog alfa se pridobiva z metodo, imenovano „tehnologija rekombinantne DNK“: izdelajo ga celice, v katere so vstavili gen (del DNK), s pomočjo katerega ga lahko tvorijo.
Simparica 5 mg chewable tablets for dogs 1.3–2.5 kg Simparica 10 mg chewable tablets for dogs >2.5–5 kg Simparica 20 mg chewable tablets for dogs >5–10 kg Simparica 40 mg chewable tablets for dogs >10–20 kg Simparica 80 mg chewable tablets for dogs >20–40 kg Simparica 120 mg chewable tablets for dogs >40–60 kg
Simparica 5 mg žvečljive tablete za pse 1,3 – 2,5 kg Simparica 10 mg žvečljive tablete za pse >2,5–5 kg Simparica 20 mg žvečljive tablete za pse >5–10 kg Simparica 40 mg žvečljive tablete za pse >10–20 kg Simparica 80 mg žvečljive tablete za pse >20–40 kg Simparica 120 mg žvečljive tablete za pse >40–60 kg
Simparica 5mg chewable tablets for dogs 1.3–2.5 kg Simparica 10 mg chewable tablets for dogs >2.5–5 kg Simparica 20 mg chewable tablets for dogs >5–10 kg Simparica 40 mg chewable tablets for dogs >10–20 kg Simparica 80 mg chewable tablets for dogs >20–40 kg Simparica 120 mg chewable tablets for dogs >40–60 kg
Simparica 5 mg žvečljive tablete za pse 1,3 – 2,5 kg Simparica 10 mg žvečljive tablete za pse >2,5–5 kg Simparica 20 mg žvečljive tablete za pse >5–10 kg Simparica 40 mg žvečljive tablete za pse >10–20 kg Simparica 80 mg žvečljive tablete za pse >20–40 kg Simparica 120 mg žvečljive tablete za pse >40–60 kg
Simparica chewable tablets
Simparica žvečljive tablete
Simparica chewable tablets for dogs
Simparica žvečljive tablete za pse
Simparica is a veterinary medicine used to treat tick, flea and sarcoptic mange infestations in dogs.
Simparica je zdravilo za uporabo v veterinarski medicini za zdravljenje infestacij s klopi in bolhami ter za zatiranje garij vrste Sarcoptes pri psih.
Simparica is available as chewable tablets (5, 10, 20, 40, 80 and 120 mg) and can only be obtained with a prescription.
Zdravilo Simparica je na voljo v obliki žvečljivih tablet (5, 10, 20, 40, 80 in 120 mg) in se izdaja le na recept.
Simparica was as effective as fipronil in reducing tick counts for up to 90 days after treatment.
Zdravilo Simparica je bilo pri zmanjševanju števila klopov enako učinkovito kot zdravilo fipronil do 90 dni po zdravljenju.
Simparica was as effective as spinosad in reducing flea counts for up to 90 days after treatment.
Zdravilo Simparica je bilo pri zmanjševanju števila bolh enako učinkovito kot zdravilo spinosad do 90 dni po zdravljenju.
Simply leave out that dose completely and then take your next dose at the right time.
Posvetujte se z zdravnikom ali s farmacevtom, preden boste vzeli katerokoli zdravilo.
Simponi 100 mg is not recommended for children and adolescents (younger than 18 years).
Zdravilo Simponi 100 mg ni priporočljivo za otroke in mladostnike (mlajše od 18 let).
Simponi 100 mg is not recommended in children aged less than 18.
Uporaba zdravila Simponi 100 mg ni priporočljiva za otroke, mlajše od 18 let.
Simponi 100 mg solution for injection in pre-filled pen golimumab
Simponi 100 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku golimumab
Simponi 100 mg solution for injection in pre-filled pen.
Simponi 100 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku Simponi 100 mg raztopina za injiciranje v napolnjeni injekcijski brizgi
Simponi 100 mg solution for injection in pre-filled syringe golimumab
Simponi 100 mg raztopina za injiciranje v napolnjeni injekcijski brizgi golimumab
Simponi 50 mg
Placebod
Simponi 50 mg + MTX
Simponi 50 mg + metotreksat
Simponi 50 mg administered once a month, on the same date each month, for children with a body weight of at least 40 kg.
Zdravilo Simponi se uporablja v odmerku 50 mg enkrat na mesec, na isti datum vsak mesec, pri otrocih, ki tehtajo najmanj 40 kg.
Simponi 50 mg given once a month, on the same date each month.
Zdravilo Simponi 50 mg dajemo enkrat na mesec, na isti datum vsak mesec.
Simponi 50 mg solution for injection in pre-filled pen golimumab
Simponi 50 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku golimumab
Simponi 50 mg solution for injection in pre-filled pen golimumab
Simponi 50 mg raztopina za injiciranje v napolnjeni injekcijski brizgi golimumab
Simponi 50 mg solution for injection in pre-filled pen.
Simponi 50 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku Simponi 50 mg raztopina za injiciranje v napolnjeni injekcijski brizgi
Simponi 50 mg solution for injection in pre-filled syringe golimumab
Simponi 50 mg raztopina za injiciranje v napolnjeni injekcijski brizgi golimumab
Simponi 50 mg*
Simponi 50 mg + metotreksat
Simponi belongs to a group of medicines called ‘TNF blockers’.
Zdravilo Simponi sodi v razred zdravil, ki jim pravimo zaviralci TNF in se uporabljajo pri odraslih
Simponi contains the active substance golimumab.
Vsebuje zdravilno učinkovino golimumab.
Simponi given as an initial dose of 200 mg, followed by 100 mg at week 2, then 100 mg every 4 weeks, thereafter (see section 5.1).
Začetni odmerek zdravila Simponi je 200 mg, ki mu sledi 100 mg v 2. tednu, nato 100 mg vsake 4 tedne (glejte poglavje 5.1).
Simponi given as an initial dose of 200 mg, followed by 100 mg at week 2, then 50 mg every 4 weeks, thereafter (see section 5.1).
Začetni odmerek zdravila Simponi je 200 mg, ki mu sledi 100 mg v 2. tednu, nato 50 mg vsake 4 tedne (glejte poglavje 5.1).
Simponi has not been studied in patients with CHF.
Zdravila Simponi niso proučevali pri bolnikih s kongestivnim srčnim popuščanjem.
Simponi in combination with MTX is indicated for the treatment of polyarticular juvenile idiopathic arthritis in children with a body weight of at least 40 kg, who have responded inadequately to previous therapy with MTX.
Zdravilo Simponi je v kombinaciji z metotreksatom indicirano za zdravljenje poliartikularnega juvenilnega idiopatskega artritisa pri otrocih, ki tehtajo najmanj 40 kg in se na predhodno zdravljenje z metotreksatom niso odzvali zadostno.
Simponi is available as pre-filled pens and syringes (50 and 100 mg) containing a solution for injection under the skin.
Na voljo je v obliki napolnjenih injekcijskih peresnikov in brizg (50 in 100 mg), ki vsebujejo raztopino za injiciranje pod kožo.
Simponi is available in packs containing 1 pre-filled pen and multipacks containing 3 (3 packs of 1) pre-filled pens.
Zdravilo Simponi je na voljo v pakiranju, ki vsebuje 1 napolnjen injekcijski peresnik in 3 (3 pakiranja po 1) napolnjene injekcijske peresnike.
Simponi is for subcutaneous use.
Zdravilo Simponi je za subkutano uporabo.
Simponi is given by injection under the skin (subcutaneously).
Zdravilo Simponi dajemo z injiciranjem pod kožo (subkutano).
Simponi is indicated for the treatment of adults with severe, active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence, who have had an inadequate response to, or are intolerant to nonsteroidal anti-inflammatory drugs (NSAIDs).
Zdravilo Simponi je indicirano za zdravljenje odraslih s hudim aktivnim neradiografskim aksialnim spondiloartritisom z objektivnimi znaki vnetja, na katera kažeta zvišana vrednost C-reaktivnega proteina (CRP) in/ali magnetnoresonančno slikanje (MRI), ki se na nesteroidna protivnetna zdravila (NSAID) niso ustrezno odzvali ali jih ne prenašajo.
Simponi is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and
Zdravilo Simponi je indicirano za zdravljenje zmerno do močno aktivnega ulceroznega kolitisa pri odraslih bolnikih, ki so se nezadostno odzvali na običajno zdravljenje, vključno s kortikosteroidi in
Simponi is not recommended for children weighing less than 40 kg with polyarticular juvenile idiopathic arthritis or in children and adolescents younger than 18 years for any other condition.
Zdravilo Simponi ni priporočljivo za otroke s poliartikularnim juvenilnim idiopatskim artritisom, ki tehtajo manj kot 40 kg, ter za otroke in mladostnike, mlajše od 18 let, ki imajo katero koli drugo bolezen.
Simponi is supplied as solution for injection in a single-use pre-filled pen.
Zdravilo Simponi je na voljo kot raztopina za injiciranje v obliki napolnjenih injekcijskih peresnikov za enkratno uporabo.
Simponi is supplied in a single use pre-filled pen called SmartJect.
Samo indukcija z zdravilom Simponi.
Simponi is used in adults who have not responded adequately to other treatments.
Zdravilo Simponi se uporablja pri bolnikih, pri katerih je bil odziv na druga zdravljenja nezadosten.
Simponi is used in combination with methotrexate (a medicine that acts on the immune system).
Zdravilo Simponi se uporablja skupaj z metotreksatom (zdravilom, ki učinkuje na imunski sistem.
Simponi must not be used in patients with tuberculosis, other severe infections, or moderate or severe heart failure (an inability of the heart to pump enough blood around the body).
Ne sme se uporabljati pri bolnikih s tuberkulozo, drugimi hudimi okužbami ali zmernim do hudim srčnim popuščanjem (nezmožnostjo srca, da črpa dovolj krvi po telesu).
Simponi or placebo were administered subcutaneously every 4 weeks.
Bolniki so prejemali zdravilo Simponi ali placebo subkutano na vsake 4 tedne.
Simponi or placebo were subcutaneously administered every 4 weeks.
Zdravilo Simponi ali placebo so jim subkutano dajali na vsake 4 tedne.
Simponi Patient Alert Card
Bolnikova opozorilna kartica Simponi
Simponi should be given concomitantly with MTX.
Sočasno zdravljenje z imunomodulatorji (azatioprinom,
Simponi should be given concomitantly with MTX.
Zdravilo Simponi uporabljamo skupaj z metotreksatom.
Simponi should be used with caution in patients with mild heart failure (NYHA class I/II).
Zdravilo Simponi je treba uporabljati previdno pri bolnikih z blagim srčnim popuščanjem (razreda I ali II po klasifikaciji NYHA).
Simponi should be used with caution in subjects with impaired hepatic function (see section 4.2).
Zdravilo Simponi uporabljajte previdno pri bolnikih, ki imajo oslabljeno delovanje jeter (glejte poglavje 4.2).
Simponi should not be given to patients with a clinically important, active infection.
Zdravila Simponi ne smete dajati bolnikom s klinično pomembno, aktivno okužbo.
Simponi should not be used if the solution is discoloured, cloudy or containing visible foreign particles.
Zdravila Simponi ne smete uporabljati, če je raztopina obarvana, motna ali vsebuje vidne tuje delce.